Epsilometer test-based determination of susceptibility of clinically important Candida isolates to conventional antifungal agents

Journal of Medical Sciences

Volumn 7, Issue 3, 2007, Pages 374-382

  Abu Elteen, Khaled H ^a   Hamad, Mawieh A ^b   Kavanagh, Kevin ^c  

^a HASHEMITE UNIVERSITY   (Jordan)

^b TAIF UNIVERSITY   (Saudi Arabia)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Antifungal susceptibility; Broth microdilution method; Candida sp.; E test

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPSILOMETER TEST; FUNGUS ISOLATION; INCUBATION TIME; JORDAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 34249850322     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2007.374.382     Document Type: Article

References (34)

1. Abu-Elteen, K.H., 2001. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan. Japn. J. Infect. Dis., 54: 103-107.
2. Abu-Elteen, K.H. and M. Hamad, 2005. Antifungal Agents for Use in Human Therapy. Fungi: Biology and Applications, Kavanagh, K. (Ed.). Wiley and Sons, UK., pp: 191-217.
3. Abu-Elteen, K.H., M. Hamad and S.A. Salah, 2006. Prevalence of oral Candida infections in diabetic patients. Bahrain Med. Bull., 28: 12-17.
4. Akpan, A. and R. Morgan, 2002. Oral candidiasis: A review. Postgrad. Med. J., 78: 455-459.
5. Araj, G.F., N.K. Daher and Z.A. Tabbarah, 1998. Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center. Int. J. Antimicrob. Agents, 10: 291-296.
6. Biodisk, A.B., 1993. E-test Technical Guide No. 4: Antifungal Susceptibility Testing of Yeasts. Solna, Sweden.
7. Birinci, A., A. Sanic and B. Durupinar, 2001. Determination of minimum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test. J. Chemother., 13: 43-46.
8. Bodey, G., M. Mardani, H. Hanna, M. Boktour, J. Abbas, E. Girgawy, R. Hachem, D. Kontoyiannis and I. Raad, 2002. The epidemiology of Candida glabrata fungemia in immunocompromised patients with cancer. Am. J. Med., 112: 380-385.
9. Chang, H.C., J.J. Chang, S.H. Chang, A.H. Huang, T.L. Wu, M.C. Lin and T.C. Chang, 2001. Evaluation of E-test for direct antifungal susceptibility testing of yeasts in positive blood cultures. J. Clin. Microbiol., 39: 1328-1333.
10. Chen, S.C.A., M.L. O'Donnell, S. Gordon and G.L. Gilbert, 1996. Antifungal susceptibility testing using the E-test: Comparison with broth macrodilution technique. J. Antimicrob. Chemother., 37: 265-273.
11. Colombo, A.L., F. Barchiesi, D.A. McGough, A.W. Fothergill and M.G. Rinaldi, 1995. Evaluation of the E-test system versus amicrotitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole. J. Antimicrob. Chemother., 36: 93-100.
12. Cuenca-Estrella, M., W. Lee-Yang, M.A. Ciblak, B.A. Arthington-Skaggs, E. Mellado, D.W. Warnock and J.L. Rodriguez-Tudela, 2002. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob. Agents Chemother., 46: 3644-3647.
13. Espinel-Ingroff, A., C.W. Kish, T.M. Kerkering, R.A. Fromtling, K. Bartizal, J.N. Galgiani, K. Villareal, M.A. Pfaller, T. Gerar-Den, M.G. Rinaldi and A. Fothergill, 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol., 30: 3138-3145.
14. Espinel-Ingroff, A., 1994. E-test for antifungal susceptibility testing of yeast. Diag. Microbiol. Infect. Dis., 19: 217-220.
15. Fidel, P.L., J.A. Vasquez and J. Sobel, 1999. Candida glabrata: Review of epidemiology, pathogenesis and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev., 12: 80-96.
16. Krcmery, V. and A.J. Barnes, 2002. Non-albicans Candida sp. causing fungemia: Pathogenicity and antifungal resistance. J. Hosp. Infect., 50: 243-260.
17. Kronvall, G. and I. Karlsson, 2001. Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation. J. Clin. Microbiol., 39: 1422-1428.
18. Lee, W. and Y. Kwak, 1999. Antifungal susceptibility testing of Candida species by flow cytometry. J. Korean Med. Sci., 14: 21-26.
19. Magaldi, S., S. Mata-Essayag, C. Hartung, C. Perez, M.T. Colella, C. Olaizola and Y. Ontiveros, 2004. Well diffusion for antifungal susceptibility testing. Int. J. Infect. Dis., 8: 39-45.
20. Majoros, L., G. Kardos, I. Pocsi and B. Szabo, 2002. Distribution and susceptibility of Candida species isolated in the medical university of Debrecen. Acta Microbiol. Immunol. Hung., 49: 351-361.
21. National Committee for Clinical Laboratory Standards, 1997. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A. NCCLS, Wayne, Pennsylvania.
22. National Committee for Clinical Laboratory Standards, 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard M38-A. NCCLS, Wayne, Pennsylvania.
23. Pfaller, M.A., S.A. Messer, A. Karlsson and A. Bolmstrom, 1998. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J. Clin. Microbiol., 36: 2586-2589.
24. Pfaller, M.A., R.N. Jones, G.V. Doern, H.S. Sader, S.A. Messer, A. Houston, S. Coffman, R.J. Hollis and the SENTRY Participant Group, 2000a. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob. Agents Chemother., 44: 747-751.
25. Pfaller, M.A., S.A. Messer, A. Houston, K. Mills, A. Bolmstrom and R.J. Jones, 2000b. Evaluation of the E-test method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media. J. Clin. Microbiol., 38: 3713-3717.
26. Pfaller, M.A., D.J. Diekema, S.A. Messer, L. Boyken, R.J. Hollis, R.N. Jones and the International Fungal Surveillance Participant Group, 2003a. In vitro activities of voriconazole, posaconazote and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol., 41: 78-83.
27. Pfaller, M.A., D.J. Diekema, S.A. Messer, L. Boyken and R.J. Hollis, 2003b. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion and Etest methods: Report from the ARTEMIS global antifungal susceptibility program, 2001. J. Clin. Microbiol., 41: 1440-1446.
28. Rex, J.H., M.A. Haller, M.G. Rinaldi, A. Polak and J.N. Galgiani, 1993. Antifungal susceptibility testing. Clin. Microbial. Rev., 6: 367-381.
29. Rex, J.H., M.A. Haller, J.N. Galgiani, M.S. Bartett, A. Espinel-Ingroff, M.A., Ghannoum, M. Lancaster, F.C. Odds, M.G. Rinaldi, T.J. Walsh and A.L. Barry, 1997. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, intraconazole and Candida infections. Clin. Infect. Dis., 24: 235-247.
30. Ruhnke, M., A. Schmidt-Westhausen, E. Engelmann and M. Trautmann, 1996. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy. J. Clin. Microbiol., 34: 3208-3211.
31. Safdar, A., V. Chaturvedi, E.W. Cross, S. Park, E.M. Bernard, D. Armstrong and D. Perlin, 2001. Prospective study of Candida species in patients at a comprehensive cancer center. Antimicrob. Agents Chemother., 45: 2129-2133.
32. Sewell, D.L., M.A. Haller and A.L. Barry, 1994. Comparison of broth macrodilution, broth microdilution and E-test antifungal susceptibility tests for fluconazole. J. Clin. Microbiol., 32: 2099-2102.
33. St-Germain, G., M. Laverdiere, R. Pelletier, A.-M. Bourgault, M. Libman, C. Lemieux and G. Noel, 2001. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: Results of a 2 year (1996 to 1998) multicenter surveillance study in Quebec. Canada. J. Clin. Microbiol., 39: 949-953.
34. Wanger, A., K. Mills, P.W. Nelson and J.H. Rex, 1995. Comparison of E-test and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: Enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob. Agents Chemother., 39: 2520-2522.